Table 2

Genes upregulated in ankle joints from SCW-induced arthritis in Lewis (LEW/N) rats

Accession no.
Gene name
Day -13.8
Day -13
Day 3
C
I







Delta
P
Delta
P
Delta
P



Angiogenesis
NM_030985
AGTR1
_
_
_
_
4.0
2.3E-05
7
L
AI639162
ANGPT1
_
_
_
_
1.8
8.5E-08
7
L
NM_031012
ANPEP
_
_
_
_
2.2
2.9E-18
7
M
AI101782
COL18A1
_
_
_
_
2.9
6.3E-26
7
L
AI170324
FIGF
_
_
1.6
9.4E-04
2.4
4.6E-11
6
L
NM_012620
SERPINE1
6.6
2.3E-06
_
_
27.6
0.0E+00
4
L
 
Cell adhesion
NM_012830
CD2
_
_
2.1
2.9E-04
_
_
3
L
NM_054001
CD36L2
_
_
_
_
2.6
5.4E-05
7
L
AF065147
CD44
2.1
2.1E-08
1.6
1.1E-03
_
_
2
M
BE108345
COL12A1
_
_
_
_
2.5
4.6E-43
7
M
AI172281
COL5A2
_
_
_
_
2.0
9.3E-06
7
H
NM_021760
COL5A3
_
_
_
_
3.1
6.9E-27
7
M
AF084544
CSPG2
2.3
2.4E-03
2.1
5.8E-04
8.9
7.2E-37
5
L
NM_053719
EMB
_
_
_
_
3.5
1.7E-19
7
L
NM_053634
FCNB
8.7
3.0E-28
8.0
1.1E-17
29.0
0.0E+00
5
M
AI236745
GALNT1
_
_
_
_
2.9
0.0E+00
7
L
NM_133298
GPNMB
_
_
2.2
3.6E-12
2.5
0.0E+00
6
H
NM_012967
ICAM1
8.9
0.0E+00
4.4
7.2E-09
4.0
2.2E-11
5
L
AF268593
ITGAM
2.0
2.6E-03
3.8
1.7E-15
6.4
3.3E-18
5
L
BI296880
ITGB3
1.5
7.0E-03
_
_
2.1
2.3E-03
4
L
AF003598
ITGB7
2.0
8.9E-14
1.6
1.2E-03
1.9
1.1E-06
5
L
U56936
KLRB1B
_
_
_
_
3.0
6.4E-03
7
L
NM_022393
MGL
_
_
2.1
7.3E-08
2.1
2.3E-11
6
L
U72660
NINJ1
_
_
_
_
1.8
6.6E-28
7
M
BE097805
PCDHGC3
_
_
1.8
3.0E-03
_
_
3
L
AJ299017
RET
_
_
_
_
2.8
1.6E-08
7
L
AF071495
SCARB1
_
_
_
_
1.8
6.9E-03
7
L
L25527
SELE
_
_
3.1
3.6E-04
_
_
3
L
D10831
SELL
1.6
9.3E-05
_
_
1.8
6.9E-06
4
L
BI296054
SELP
1.8
7.1E-08
1.9
2.6E-07
2.2
4.2E-13
5
L
AI176034
TNC
_
_
_
_
2.6
3.7E-26
7
M
AF159103
TNFIP6
2.2
6.2E-04
2.2
3.1E-05
5.0
1.3E-21
5
L
NM_031590
WISP2
_
_
_
_
2.6
0.0E+00
7
M
 
Chemotaxis
NM_053619
C5AR1
1.6
5.0E-06
2.4
9.6E-21
2.7
2.8E-32
5
M
NM_019205
CCL11
3.9
2.3E-03
3.7
2.3E-07
_
_
2
L
NM_057151
CCL17
2.2
1.1E-05
_
_
_
_
1
L
AF053312
CCL20
8.3
7.3E-19
10.2
2.8E-10
15.5
3.5E-32
5
L
U22414
CCL3
15.3
1.7E-19
3.2
3.8E-05
2.1
1.1E-08
5
L
U06434
CCL4
6.0
1.5E-17
_
_
_
_
1
L
NM_031116
CCL5
_
_
2.6
5.9E-11
2.0
1.1E-03
6
L
NM_020542
CCR1
5.2
1.4E-15
2.1
3.0E-05
2.1
3.2E-03
5
L
NM_021866
CCR2
5.1
2.7E-07
3.3
2.9E-05
6.9
2.7E-13
5
L
NM_053960
CCR5
6.2
4.3E-19
6.0
1.8E-09
6.0
1.4E-10
5
L
D87927
CINC2
3.5
7.0E-03
_
_
_
_
1
L
AF253065
CKLF1
3.3
6.3E-09
3.0
2.7E-07
8.2
8.6E-08
5
L
NM_022218
CMKLR1
_
_
2.5
3.4E-03
_
_
3
L
U22520
CXCL10
3.2
4.4E-09
2.5
9.0E-03
1.4
1.3E-03
5
L
NM_053647
CXCL2
38.7
1.6E-07
2.3
9.1E-03
2.6
1.0E-03
5
L
NM_022214
CXCL6
2.2
2.3E-04
_
_
7.5
3.2E-06
4
L
NM_017183
CXCR2
10.6
1.5E-07
3.6
1.3E-03
_
_
2
L
NM_053415
CXCR3_V1
_
_
_
_
1.9
9.5E-04
7
L
AA945737
CXCR4
1.6
1.7E-03
1.7
3.9E-04
3.4
2.7E-15
5
L
NM_030845.1
GRO
17.1
0.0E+00
23.0
2.4E-04
19.8
1.8E-12
5
L
NM_053321
PTAFR
_
_
2.5
2.0E-03
_
_
3
L
NM_031530
SCYA2
3.4
6.0E-26
3.2
1.8E-16
6.0
0.0E+00
5
M
 
Complement activation
D88250
C1S
_
_
1.6
4.4E-03
1.8
7.5E-22
6
M
_
C2
6.9
9.20E-42
3.5
1.28E-11
16.8
0.0E+00
5
L
NM_016994.1
C3
2.7
2.0E-10
3.0
5.4E-12
10.4
0.0E+00
5
L
AI169829
MASP1
_
_
_
_
2.4
8.5E-08
7
L
 
Immune response/inflammatory response
XM_215303
RT1.S3
_
_
2.0
0.0012
1.6
1.5E-03
6
L
AF307302
BTNL2
_
_
2.1
1.0E-15
3.2
0.0E+00
6
M
NM_021744
CD14
2.8
7.8E-18
2.0
4.4E-06
1.7
7.3E-05
5
M
NM_012705
CD4
_
_
_
_
1.8
1.3E-07
7
L
NM_013069
CD74
_
_
2.2
3.5E-18
2.7
1.1E-31
6
H
NM_031538
CD8a
_
_
9.5
2.7E-03
10.9
6.2E-07
6
L
BI282755
EDG3
_
_
_
_
2.1
5.9E-03
7
L
X73371
FCGR2
3.1
1.4E-20
3.8
2.4E-08
6.5
0.0E+00
5
L
NM_053843
FCGR3
2.2
3.3E-15
2.0
2.8E-12
2.6
0.0E+00
5
M
NM_133624
GBP2
3.4
6.2E-35
_
_
1.5
3.8E-06
4
L
AF176534
HFE
_
_
_
_
1.8
6.6E-03
7
L
XM_215347
HLA-DMA
_
_
2.0
1.22E-14
2.7
0.0E+00
6
L
_
HLA-DMB
_
_
2.0
5.42E-15
3.2
1.1E-13
6
M
NM_022605
HPSE
_
_
_
_
1.9
3.0E-09
7
L
NM_133533
IGB
_
_
_
_
2.9
8.4E-09
7
L
NM_053374
IGIFBP
_
_
2.2
7.2E-03
_
_
3
L
AJ245643
IL1a
2.7
1.2E-03
_
_
_
_
1
L
NM_031512
IL1b
22.0
1.1E-30
9.5
4.5E-15
5.7
1.6E-35
5
L
NM_053953
IL1R2
2.5
1.9E-15
_
_
_
_
1
L
NM_022194
IL1RN
7.4
2.8E-03
_
_
_
_
1
L
NM_012589
IL6
10.0
7.3E-17
20.7
7.9E-04
21.4
5.5E-17
5
L
NM_013110
IL7
_
_
_
_
2.8
2.4E-04
7
L
NM_012591
IRF1
2.9
4.7E-13
2.6
2.8E-08
3.3
2.0E-13
5
L
NM_130741
LCN2
2.4
1.7E-09
3.4
9.8E-12
13.2
0.0E+00
5
M
BF282471
LCP2
2.6
2.2E-04
3.3
2.4E-04
6.2
4.4E-06
5
L
NM_022634
LST1
4.9
6.2E-14
6.3
6.4E-14
16.7
2.0E-36
5
L
NM_031634
MEFV
2.7
1.9E-07
_
_
1.9
7.4E-05
4
L
X52711
MX1
_
_
2.8
4.9E-07
1.9
2.1E-15
6
L
NM_134350
MX2
_
_
2.9
5.9E-04
_
_
3
L
NM_053734
NCF1
_
_
2.0
9.4E-16
2.0
3.7E-06
6
L
AA858801
NFKB1
2.1
1.1E-12
_
_
_
_
1
M
AW672589
NFKBIA
2.5
5.2E-36
_
_
_
_
1
M
L12562
NOS2A
6.0
1.9E-05
_
_
_
_
1
L
Z18877
OAS1
1.6
8.4E-06
2.4
3.8E-06
1.8
3.7E-06
5
L
NM_053288
ORM1
_
_
2.0
7.0E-04
3.1
9.8E-19
6
L
NM_031713
PIRB
2.4
3.9E-06
2.5
2.6E-06
3.3
7.6E-10
5
L
AF349115
PPBP
_
_
_
_
3.2
8.5E-03
7
L
NM_080767
PSMB8
1.5
3.0E-03
2.3
2.0E-09
3.3
0.0E+00
5
L
AI599350
PSMB9
2.0
2.0E-07
2.1
7.4E-09
3.7
2.3E-25
5
L
AB048730
PTGES
8.2
8.1E-40
3.9
1.0E-04
2.4
6.7E-04
5
L
NM_012645
RT1Aw2
_
_
3.3
0.000334
5.4
2.7E-10
6
L
X57523.1
TAP1
1.6
2.8E-04
1.6
9.8E-03
2.4
5.6E-07
5
L
NM_021578
TGFB1
_
_
2.1
8.4E-06
2.6
1.7E-10
6
L
AA819227
TNF
11.1
1.3E-27
2.5
1.9E-04
_
_
2
L
BM390522
TNFRSF1b
14.3
8.2E-19
3.7
4.2E-06
8.0
3.5E-06
5
L
NM_012759
VAV1
4.6
7.1E-05
7.6
1.2E-07
10.8
1.2E-12
5
L
 
Proteolysis and peptidolysis
NM_024400
ADAMTS1
3.1
9.2E-16
2.1
7.0E-04
3.5
1.3E-16
5
L
AA849399
CTSZ
1.6
6.4E-08
1.5
8.9E-12
3.4
1.6E-33
5
M
NM_012582
HP
2.1
4.8E-20
_
_
1.7
5.5E-05
4
L
NM_031670
KDAP
18.8
8.7E-23
6.6
5.0E-07
48.2
2.3E-37
5
L
AF154349
LGMN
_
_
2.1
1.8E-06
2.8
0.0E+00
6
M
NM_053963
MMP12
_
_
4.1
8.6E-05
7.7
8.2E-13
6
L
M60616.1
MMP13
_
_
_
_
2.0
4.7E-08
7
M
X83537
MMP14
_
_
_
_
1.8
2.1E-17
7
H
NM_053606
MMP23A
_
_
_
_
2.1
1.6E-11
7
L
NM_133523
MMP3
2.9
5.7E-29
2.7
1.4E-12
9.3
0.0E+00
5
H
AI102069
NSF
_
_
1.7
8.1E-03
1.8
3.9E-04
6
L
BF549923
PCSK5
_
_
1.8
1.5E-03
3.4
7.5E-21
6
L
X63434
PLAU
_
_
_
_
1.8
2.9E-14
7
M
AF007789
PLAUR
6.2
4.6E-04
_
_
4.9
7.2E-03
4
L
NM_053372
SLPI
2.6
8.3E-09
2.6
5.4E-22
7.0
0.0E+00
5
M
NM_053819
TIMP1
2.2
0.0E+00
1.8
5.9E-09
6.4
0.0E+00
5
H
NM_053299
UBD
_
_
_
_
4.7
9.1E-04
7
L
 
Signal transduction
NM_019285
ADCY4
_
_
_
_
2.3
3.5E-05
7
L
BF285345
ARRB2
_
_
1.8
2.5E-05
2.5
6.5E-20
6
L
NM_057196
BAIAP2
_
_
4.4
5.5E-03
_
_
3
L
NM_012766
CCND3
_
_
_
_
2.1
6.0E-08
7
L
NM_013169
CD3d
_
_
_
_
3.9
3.7E-07
7
L
AF065161
CISH
2.5
1.1E-03
_
_
_
_
1
L
NM_031352
DBNL
_
_
1.7
6.6E-11
1.8
1.2E-04
6
L
BI278868
EPIM
_
_
_
_
2.1
6.7E-03
7
L
NM_024147
EVL
_
_
_
_
3.6
8.0E-09
7
L
L02530
FZD2
_
_
_
_
3.3
6.3E-07
7
L
NM_030829.1
GPRK5
_
_
_
_
2.0
1.0E-04
7
L
U87863.1
HGS
_
_
1.9
3.6E-03
_
_
3
L
AY044251
IL13RA1
_
_
_
_
3.2
3.0E-08
7
L
AI178808
IL2RG
2.4
8.1E-14
2.5
10.0E-23
5.6
0.0E+00
5
L
NM_133380
IL4R
_
_
6.5
4.8E-05
7.5
3.4E-18
6
L
NM_017020
IL6R
_
_
1.8
2.4E-10
1.8
1.6E-12
6
L
NM_019311
INPP5D
_
_
_
_
1.9
7.9E-20
7
L
NM_012798
MAL
2.1
1.9E-04
_
_
_
_
1
L
AW533194
MAPK10
2.4
5.7E-03
_
_
_
_
1
L
AF411318
MT1A
2.6
2.4E-27
2.4
2.2E-04
3.4
6.0E-34
5
M
NM_012613
NPR1
_
_
_
_
3.3
1.9E-03
7
L
U32497
P2RX4
_
_
1.6
4.2E-15
1.9
2.5E-20
6
L
AF202733
PDE4B
2.4
1.1E-07
2.5
8.1E-04
2.3
2.5E-03
5
L
BE099769
PLAA
_
_
2.5
8.7E-03
_
_
3
L
X04440
PRKCB1
_
_
_
_
1.8
3.3E-08
7
L
AF254800
RAB0
_
_
_
_
1.9
7.8E-04
7
L
NM_019250
RALGDS
1.9
8.1E-05
_
_
_
_
1
L
NM_021661
RGS19
_
_
_
_
1.8
1.8E-05
7
L
AF321837
RGS2
_
_
_
_
2.3
2.4E-09
7
L
NM_053338
RRAD
7.0
5.2E-05
4.8
1.6E-05
4.0
6.5E-03
5
L
BE117558
SFRP1
_
_
_
_
1.8
2.4E-08
7
M
BF389682
SOCS3
3.8
0.0E+00
2.0
1.2E-05
3.6
3.2E-33
5
L
NM_022230
STC2
_
_
3.1
2.2E-03
_
_
3
L
BG668493
STMN2
_
_
2.3
2.6E-06
14.0
7.2E-42
6
L
U21683
SYK
_
_
_
_
1.8
2.1E-05
7
L

Genes upregulated (Delta > 1.8 and P < 0.01) on days -13.8 (4 hours after intra-articular injection of streptococcal cell wall [SCW]), -13 and 3 are grouped by their general ontology and clustered based on their similarity in terms of pattern of expression (C) and expression level (I). Data are expressed as the mean fold increase in gene expression (Delta) in SCW-injected animals as compared with expression in the corresponding phosphate-buffered saline (PBS) control group (four to five animals/group), along with the P value. C, number of clusters to which the gene corresponds (trend plots are given in Fig. 6); I, intensity of gene expression (L = low intensity [0–500], M = medium intensity [500–1500], H = high intensity [1500–4000]). A line (_) in the Delta or P cell indicates that the gene was not found to be differentially expressed at that particular time point.

Rioja et al. Arthritis Res Ther 2005 7:R101   doi:10.1186/ar1458

Open Data